George A. Heavner

1.9k total citations
48 papers, 1.4k citations indexed

About

George A. Heavner is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, George A. Heavner has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 12 papers in Immunology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in George A. Heavner's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Chemical Synthesis and Analysis (10 papers) and Glycosylation and Glycoproteins Research (9 papers). George A. Heavner is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Chemical Synthesis and Analysis (10 papers) and Glycosylation and Glycoproteins Research (9 papers). George A. Heavner collaborates with scholars based in United States, Russia and Slovakia. George A. Heavner's co-authors include Robert L. Letsinger, Jacqueline Benson, Jill Giles‐Komar, David J. Shealy, Bernard J. Scallon, David Peritt, Mary Ann Mascelli, Gideon Goldstein, Tapan Audhya and Geoffrey L. Greene and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

George A. Heavner

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George A. Heavner United States 18 601 438 211 194 184 48 1.4k
Eric G. Bremer United States 16 814 1.4× 394 0.9× 153 0.7× 115 0.6× 227 1.2× 19 1.5k
Damian Grobelny United States 15 563 0.9× 314 0.7× 301 1.4× 269 1.4× 79 0.4× 36 1.7k
David Andrews United Kingdom 24 675 1.1× 214 0.5× 335 1.6× 106 0.5× 112 0.6× 65 1.6k
Christoph Kannicht Germany 24 1.0k 1.7× 320 0.7× 285 1.4× 397 2.0× 92 0.5× 65 1.9k
Masayuki Tsuchiya Japan 23 869 1.4× 626 1.4× 81 0.4× 157 0.8× 133 0.7× 39 1.9k
Daikichi Fukushima Japan 19 793 1.3× 179 0.4× 313 1.5× 139 0.7× 54 0.3× 31 1.9k
Alan H. Davidson United Kingdom 17 588 1.0× 295 0.7× 334 1.6× 239 1.2× 88 0.5× 43 1.7k
Michael Furlong United States 20 562 0.9× 733 1.7× 181 0.9× 145 0.7× 134 0.7× 31 1.8k
Joseph W. Leone United States 17 888 1.5× 190 0.4× 134 0.6× 104 0.5× 89 0.5× 38 1.5k
G. A. Turner United Kingdom 25 1.2k 2.0× 462 1.1× 172 0.8× 84 0.4× 170 0.9× 79 2.1k

Countries citing papers authored by George A. Heavner

Since Specialization
Citations

This map shows the geographic impact of George A. Heavner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George A. Heavner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George A. Heavner more than expected).

Fields of papers citing papers by George A. Heavner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George A. Heavner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George A. Heavner. The network helps show where George A. Heavner may publish in the future.

Co-authorship network of co-authors of George A. Heavner

This figure shows the co-authorship network connecting the top 25 collaborators of George A. Heavner. A scholar is included among the top collaborators of George A. Heavner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George A. Heavner. George A. Heavner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benson, Jacqueline, David Peritt, Bernard J. Scallon, et al.. (2011). Discovery and mechanism of ustekinumab. mAbs. 3(6). 535–545. 254 indexed citations
2.
Luo, Jinquan, Sheng‐Jiun Wu, Eilyn R. Lacy, et al.. (2010). Structural Basis for the Dual Recognition of IL-12 and IL-23 by Ustekinumab. Journal of Molecular Biology. 402(5). 797–812. 79 indexed citations
3.
Cunningham, Mark R., et al.. (2006). Engineering human IL-18 with increased bioactivity and bioavailability. Cytokine. 34(1-2). 114–124. 10 indexed citations
4.
Bugelski, Peter J., J. W. Fisher, Ian E. James, et al.. (2005). Pharmacokinetics and Pharmacodynamics of CNTO 528, a Novel Erythropoietin Receptor Agonist in Normal and Anemic Rats.. Blood. 106(11). 4261–4261. 4 indexed citations
5.
Kruszynski, Marian, Ping Tsui, Nicole Stowell, et al.. (2005). Synthetic, site-specific biotinylated analogs of human MCP-1. Journal of Peptide Science. 12(5). 354–360. 4 indexed citations
6.
Heavner, George A., et al.. (2005). An in vivo model to assess factors that may stimulate the generation of an immune reaction to erythropoietin. International Immunopharmacology. 6(4). 647–655. 24 indexed citations
7.
Kruszynski, Marian, Nicole Stowell, Anuk Das, et al.. (2005). Synthesis and biological characterization of human monocyte chemoattractant protein 1 (MCP‐1) and its analogs. Journal of Peptide Science. 12(1). 25–32. 5 indexed citations
8.
Knight, David, Robert E. Jordan, Marian Kruszynski, et al.. (2004). Pharmacodynamic enhancement of the anti-platelet antibody Fab abciximab by site-specific pegylation. Platelets. 15(7). 409–418. 19 indexed citations
9.
Louneva, Natalia, et al.. (2002). A monoclonal antibody and an enzyme immunoassay for human Ala-IL-877. Journal of Immunological Methods. 270(1). 37–51. 5 indexed citations
10.
11.
Heavner, George A.. (1996). Active sequences in cell adhesion molecules: targets for therapeutic intervention. Drug Discovery Today. 1(7). 295–304. 15 indexed citations
12.
Kruszynski, Marian, Marian T. Nakada, Susan H. Tam, et al.. (1996). Determination of the Core Sequence of an Antagonist of Selectin-Dependent Leukocyte Adhesion and Correlation of Its Structure with Molecular Modeling Studies. Archives of Biochemistry and Biophysics. 331(1). 23–30. 2 indexed citations
13.
Taylor, Alexander H., George A. Heavner, Mark Nedelman, et al.. (1995). Lipopolysaccharide (LPS) Neutralizing Peptides Reveal a Lipid A Binding Site of LPS Binding Protein. Journal of Biological Chemistry. 270(30). 17934–17938. 66 indexed citations
14.
Heavner, George A., et al.. (1993). Peptides from multiple regions of the lectin domain of P‐selectin inhibiting neutrophil adhesion. International journal of peptide & protein research. 42(5). 484–489. 14 indexed citations
15.
Heavner, George A., et al.. (1990). Isolation, identification, and characterization of a palladium complex in the catalytic deprotection of a protected peptide. International journal of peptide & protein research. 36(2). 188–192. 2 indexed citations
16.
Heavner, George A., Tapan Audhya, & Gideon Goldstein. (1990). Peptide analogs of thymopentin distinguish distinct thymopoietin receptor specificities on two human T cell lines. Regulatory Peptides. 27(2). 257–262. 3 indexed citations
17.
Tjoeng, Foe S. & George A. Heavner. (1983). Synthesis of a new photolabile support. 4-(2-Chloropropionyl)phenylacetamidomethyl-resin and its application in solid-phase peptide synthesis. The Journal of Organic Chemistry. 48(3). 355–359. 25 indexed citations
18.
Krishna, N. Rama, et al.. (1983). Proton nuclear magnetic resonance investigation of the active site fragment of splenin, an immunoregulatory polypeptide. Journal of the American Chemical Society. 105(23). 6930–6934. 14 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric G. Bremer Breakdown of academic impact, for papers by Damian Grobelny Breakdown of academic impact, for papers by David Andrews Breakdown of academic impact, for papers by Christoph Kannicht Breakdown of academic impact, for papers by Masayuki Tsuchiya Breakdown of academic impact, for papers by Daikichi Fukushima Breakdown of academic impact, for papers by Alan H. Davidson Breakdown of academic impact, for papers by Michael Furlong Breakdown of academic impact, for papers by Joseph W. Leone Breakdown of academic impact, for papers by G. A. Turner
Rankless by CCL
2026